Syntheses of Melanotan II and YSL Amide by Ajiphase® Methodology
- 作者: Sanguliya T.A.1, Antipova A.O.1, Shkavrov S.V.1, Épshtein N.B.1
- 
							隶属关系: 
							- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)
 
- 期: 卷 53, 编号 5 (2019)
- 页面: 462-466
- 栏目: Drug Synthesis Methods and Manufacturing Technology
- URL: https://ogarev-online.ru/0091-150X/article/view/245812
- DOI: https://doi.org/10.1007/s11094-019-02020-0
- ID: 245812
如何引用文章
详细
The promising antitumor peptides Melanotan II and YSL amide were synthesized for the first time in gram quantities in overall yields of 72 and 50%, respectively, by Ajiphase® methodology. This method was shown to be promising for peptide manufacturing. The proposed methods are as convenient as polymer-phase syntheses with the reagent consumption and associated analytical simplicity of classical solution syntheses.
作者简介
T. Sanguliya
National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)
														Email: NBEpshtejn@mephi.ru
				                					                																			                												                	俄罗斯联邦, 							Moscow, 115409						
A. Antipova
National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)
														Email: NBEpshtejn@mephi.ru
				                					                																			                												                	俄罗斯联邦, 							Moscow, 115409						
S. Shkavrov
National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)
														Email: NBEpshtejn@mephi.ru
				                					                																			                												                	俄罗斯联邦, 							Moscow, 115409						
N. Épshtein
National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)
							编辑信件的主要联系方式.
							Email: NBEpshtejn@mephi.ru
				                					                																			                												                	俄罗斯联邦, 							Moscow, 115409						
补充文件
 
				
			 
						 
						 
					 
						 
						 
				 
  
  
  
  
  电邮这篇文章
			电邮这篇文章  开放存取
		                                开放存取 ##reader.subscriptionAccessGranted##
						##reader.subscriptionAccessGranted## 订阅存取
		                                		                                        订阅存取
		                                					